Converge Global, Inc. Stock Other OTC
Equities
US21247M2098
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2020 | 281K 382K | Sales 2021 | 1.03M 1.4M | Capitalization | 8.55M 11.63M |
---|---|---|---|---|---|
Net income 2020 | -12M -16.33M | Net income 2021 | -10M -13.61M | EV / Sales 2020 | 50.5 x |
Net Debt 2020 | 1.2M 1.63M | Net Debt 2021 | 3.69M 5.02M | EV / Sales 2021 | 11.9 x |
P/E ratio 2020 |
-0.33
x | P/E ratio 2021 |
-0.62
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Jesus Quintero
CEO | Chief Executive Officer | 62 | 18-08-30 |
Glen Bonilla
SAM | Sales & Marketing | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jesus Quintero
CEO | Chief Executive Officer | 62 | 18-08-30 |
Marco Guerrero
BRD | Director/Board Member | 51 | 20-06-11 |
1st Jan change | Capi. | |
---|---|---|
-9.01% | 1.19B | |
-20.09% | 130M | |
+0.16% | 73.18M | |
+3.39% | 59.15M | |
+1.54% | 56.15M | |
-2.99% | 50.57M |